Biotinylated Human latent GDF-8 Protein, His Tag, ultra sensitivity (primary amine labeling) (pro & latent) (MALS verified)

사용자 리뷰
제품 번호/규격
가격
수량
GD8-H8243-25ug
$300.00
GD8-H8243-200ug
$1290.00
ETA of in-stock products:2 business days
총 항목 수 제품 금액$ 0

제품 세부정보

  • Synonyms

    GDF-8, Myostatin, GDF8, MSTN, Growth, differentiation factor 8

  • Source

    Biotinylated Human latent GDF-8 Protein, His Tag, primary amine labeling (GD8-H8243) is expressed from human 293 cells (HEK293). It contains AA Asn 24 - Ser 375 (Accession # O14793). It is the biotinylated form of Human latent GDF-8, His Tag (Cat. No. GD8-H5243).

    Predicted N-terminus: His

    Request for sequence
  • Molecular Characterization

    GDF-8 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the N-terminus.

    The protein has a calculated MW of 42.0 kDa. The protein migrates as 38 kDa and 50-53 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

    The protein is designed as a dimer.

  • Labeling

    The primary amines in the side chains of lysine residues and the N-terminus of the protein are conjugated with biotins using standard chemical labeling method. A standard biotin reagent (13.5 angstroms) is used in this product.

  • Protein Ratio

    Passed as determined by the HABA assay / binding ELISA.

  • Purity

    >90% as determined by SDS-PAGE.

    >95% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in 0.2 M Arginine, PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

고객님도 확인한 상품

데이터 표시

  • SDS-PAGE

    GDF-8 SDS-PAGE

    Biotinylated Human latent GDF-8 Protein, His Tag, primary amine labeling on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    GDF-8 SEC-MALS

    The purity of Biotinylated Human latent GDF-8 Protein, His Tag, primary amine labeling (Cat. No. GD8-H8243) is more than 95% and the molecular weight of this protein is around 90-110 kDa verified by SEC-MALS.

    Report
  • Bioactivity-SPR

     GDF-8 SPR

    Human Follistatin Protein, His Tag, premium grade (Cat. No. FON-H52H4) immobilized on CM5 Chip can bind Biotinylated Human latent GDF-8 Protein, His Tag (Cat. No. GD8-H8243) with an affinity constant of 248 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

    Protocol
  •  GDF-8 SPR

    Apitegromab captured on Protein A Chip can bind Biotinylated Human latent GDF-8 Protein, His Tag, primary amine labeling (Cat. No. GD8-H8243) with an affinity constant of 17.1 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

    Protocol

사용자 리뷰
댓글 남기기

배경 소개

Growth differentiation factor 8 (GDF8), also known as myostatin, is a unique member of the transforming growth factor-β superfamily that is expressed in human granulosa cells and has important roles in regulating a variety of ovarian functions. GDF8 acts as a negative regulator of skeletal muscle growth and differentiation. In addition to the expression in the musculoskeletal system, GDF8 is also expressed in various tissues, including the reproductive system.

프론티어 진행

 
의약품 개발 진행
  • 영어 이름:

    Growth/differentiation factor 8

  • 카테고리:

  • 상장 의약품 수:

    0 상세

  • 임상 의약품 수:

    8 상세

  • 최고 개발 단계:

    NDA/BLA

연락하기
신약 후보물질 라이선싱
더 많이 알아보기
  • 기본 제품 정보
  • 제품 세부정보
  • 고객님도 확인한 상품
  • 데이터 표시
  • 사용자 리뷰
  • 배경
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호